Startos Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 09-12-2024
- Paid Up Capital ₹ 0.10 M
as on 09-12-2024
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit 394.21%
(FY 2022)
- Ebitda 102.23%
(FY 2022)
- Net Worth 8.56%
(FY 2022)
- Total Assets 1.10%
(FY 2022)
About Startos Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ambrish Pandya, Vipulkumar Thakkar, Keyurkumar Patel, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230GJ2010PTC061484
- Company No.
061484
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jul 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Startos Healthcare Private Limited offer?
Startos Healthcare Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Injection, Common Disease Medicines, Pharmaceutical Capsules, Anti Cancer Medicines, Pain Relief Drugs & Pharmaceuticals, Osteoporosis Medications, Cardiovascular Drugs & Medication, Diabetes Medicine, Anti Inflammatory Drugs.
Who are the key members and board of directors at Startos Healthcare?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ambrish Pandya  | Director | 08-Jul-2010 | Current |
| Vipulkumar Thakkar | Director | 08-Jul-2010 | Current |
| Keyurkumar Patel | Director | 08-Jul-2010 | Current |
| Ramavtar Pareek | Director | 25-Apr-2011 | Current |
Financial Performance of Startos Healthcare.
Startos Healthcare Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 394.21% increase in profit. The company's net worth moved up by a moderate rise of 8.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Startos Healthcare?
In 2020, Startos Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Startos Healthcare?
Startos Healthcare has a workforce of 30 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Startos Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Startos Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
